Assessing the site of increased intestinal permeability in coeliac and inflammatory bowel disease

Gut

Volumn 38, Issue 6, 1996, Pages 864-869

  Teahon, K ^a,c   Somasundaram, S ^b   Smith, T ^b   Menzies, I ^b   Bjarnason, I ^b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

coeliac disease; Crohn's disease; inflammatory bowel disease; intestinal function; intestinal permeability; ulcerative colitis

Indexed keywords

3 METHYLGLUCOSE; COBALT 57; CYANOCOBALAMIN; EDETATE CHROMIUM CR 51; SALAZOSULFAPYRIDINE;

ADULT; AGED; ARTICLE; CELIAC DISEASE; CLINICAL ARTICLE; COLON; CONTROLLED STUDY; CROHN DISEASE; FEMALE; HUMAN; ILEUM; INTESTINE ABSORPTION; INTESTINE MUCOSA PERMEABILITY; ISOTOPE LABELING; JEJUNUM; MALE; PRIORITY JOURNAL; RADIOISOTOPE DISTRIBUTION; ULCERATIVE COLITIS; URINARY EXCRETION;

EID: 0030055477     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.38.6.864     Document Type: Article

References (22)

1. Menzies IS. Transmucosal passages of inert molecules in health and disease. In: Skadhauge E, Heintze K, eds. Intestinal absorption and secretion. Falk Symposium 36. Lancaster: MTP Press, 1984: 527-43.
2. Bjarnason I, Macpherson A, Hollander D. Intestinal permeability: an overview. Gastroenterology 1995; 108: 1566-81.
3. Bjarnason I, Maxton D, Reynolds AP, Catt S, Peters TJ, Menzies IS. A comparison of 4 markers of intestinal permeability in control subjects and patients with coeliac disease. Scand J Gastroenterol 1993; 26: 630-9.
4. Maxton DG, Bjarnason I, Reynolds AP, Catt SD, Peters TJ, Menzies IS. Lactulose, 51CrEDTA, L-rhamnose and polyethylene glycol 400 as probe markers for 'in vivo' assessment of human intestinal permeability. Clin Sci 1986; 71: 71-80.
5. Jenkins AP, Nukajam WS, Menzies IS, Creamer B. Simultaneous administration of lactulosc and 51Cr-ethylenediaminetetraacetic acid. A test to distinguish colonic from small-intestinal permeability change. Scand J Gastroenterol 1992; 27: 769-73.
6. Qvist H, Somasundaram S, Macpherson A, Menzies IS, Giercksky K, Bjarnason I. The effect of pelvic irradiation on small and large intestinal absorption and permeability in man. Gastroenterology 1994; 106: A430.
7. Fordtran JS, Clodi PH, Soergel KH, Ingelfinger JF. Sugar absorption tests, with special reference to 3-0-methyl-D-glucose and D-xylose. Ann Intern Med 1962; 57: 883-91.
8. Kapadia CR, Serfilippi C, Voloshin KDR. Intrinsic-factor mediated absorption of cobalamine by pig ileal cells. J Clin Invest 1983; 71: 440-7.
9. Kellow JE, Borody TJ, Phillips SF, Haddad AC, Brown ML. Sulphapyridine appearance in plasma after salicylazosulfapyridine. Gastroenterology 1986; 91: 396-400.
10. Best WR, Becktel JM, Singleton JW, Kem F. Development of a Crohn's disease activity index. Gastroenterology 1975; 70: 439-44.
11. Truelove SC, Witts LJ. Cortisone in ulcerative colitis. Final report on a therapeutic trial. BMJ 1955; 2: 1041-8.
12. Doscherholmen A, Hagen PS. Delay of absorption of radio-labelled cyanocobalamine in the intestinal wall in the presence of intrinsic factor. J Lab Clin Med 1959; 54: 434-9.
13. Chandler C, Garnett ES, Parsons V, Veall N. Glomerular rate measurement in man by the single injection method using 51CrEDTA. Clin Sci 1969; 37: 169-80.
14. Menzies IS, Mount JN, Wheeler MJ. Quantitative estimation of clinically important monosaccharides in plasma by pid thin layer chromatography. Ann Clin Biochem 1978; 15: 65-76.
15. Chungi VS, Gurvinder SR, Shargel L. A simple and rapid liquid Chromatographic method for the determination of major metabolites of sulphasalazine in biologic fluids. J Pharm Sci 1989; 78: 235-8.
16. Peters TJ, Hofbrand AV. Absorption of vitamin B12 by the guinea pig. I subcellular localisation of vitamin B12 in ileal enterocyte during absorption. Br J Haematol 1970; 19: 369-82.
17. Jenkins WJ, Empsow R, Jewel DP, Taylor KB. The subcellular localisation of vitamin B12 during absorption in guinea pig ileum. Gut 1982; 22: 617-23.
18. Bjarnason I, Peters TJ. In vitro determination of intestinal permeability: demonstration of a persisting defect in patients with coeliac disease. Gut 1984; 25: 145-50.
19. Dawson DJ, Lobley RW, Burrows PC, Notman JA, Mahon M, Holmes R. Changes in jejunal permeability and passive permeation of sugars in intestinal biopsies in coeliac disease and Crohn's disease. Clin Sci 1988; 74: 427-31.
20. Madara JL, Trier JS. Structural abnormalities of jejunal epithelial cell membranes in coeliac sprue. Lab Invest 1980; 43: 254-61.
21. Rask-Madsen J, Schwartz M. Absorption of 51CrEDTA in ulcerative colitis following rectal instillation. Scand J Gastroenterol 1979; 5: 361-8.
22. O'Morain C, Abelon AC, Chervli LR, Fleischner GM, Das KM.51CrEDTA a useful test in the assessment of inflammatory bowel disease. J Lab Clin Med 1986; 108: 430-5.